Sartorius Aktiengesellschaft (SSSGY)
USD 39.0
(0.0%)
USD 39.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 3.39 Billion EUR | -18.66% |
| 2022 | 4.17 Billion EUR | 21.03% |
| 2021 | 3.44 Billion EUR | 47.68% |
| 2020 | 2.33 Billion EUR | 27.84% |
| 2019 | 1.82 Billion EUR | 16.66% |
| 2018 | 1.56 Billion EUR | 11.5% |
| 2017 | 1.4 Billion EUR | 8.02% |
| 2016 | 1.3 Billion EUR | 16.64% |
| 2015 | 1.11 Billion EUR | 25.09% |
| 2014 | 891.16 Million EUR | 0.44% |
| 2013 | 887.26 Million EUR | 4.91% |
| 2012 | 845.71 Million EUR | 15.36% |
| 2011 | 733.1 Million EUR | 11.19% |
| 2010 | 659.31 Million EUR | 9.51% |
| 2009 | 602.08 Million EUR | -1.56% |
| 2008 | 611.62 Million EUR | 3.84% |
| 2007 | 589.02 Million EUR | 13.05% |
| 2006 | 521.05 Million EUR | 7.59% |
| 2005 | 484.3 Million EUR | 3.58% |
| 2004 | 467.56 Million EUR | 5.72% |
| 2003 | 442.26 Million EUR | -7.19% |
| 2002 | 476.52 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 860.7 Million EUR | 5.01% |
| 2024 Q1 | 819.6 Million EUR | -3.55% |
| 2024 Q3 | 793.6 Million EUR | -7.8% |
| 2023 Q3 | 810.7 Million EUR | -2.56% |
| 2023 Q4 | 849.8 Million EUR | 4.82% |
| 2023 FY | 3.39 Billion EUR | -18.66% |
| 2023 Q1 | 903.2 Million EUR | -14.94% |
| 2023 Q2 | 832 Million EUR | -7.88% |
| 2022 Q4 | 1.06 Billion EUR | 0.87% |
| 2022 Q3 | 1.05 Billion EUR | 1.64% |
| 2022 FY | 4.17 Billion EUR | 21.03% |
| 2022 Q2 | 1.03 Billion EUR | 1.05% |
| 2022 Q1 | 1.02 Billion EUR | 11.11% |
| 2021 Q1 | 791.1 Million EUR | 20.66% |
| 2021 FY | 3.44 Billion EUR | 47.68% |
| 2021 Q4 | 922.32 Million EUR | 2.74% |
| 2021 Q2 | 838.1 Million EUR | 5.94% |
| 2021 Q3 | 897.7 Million EUR | 7.11% |
| 2020 Q1 | 509.9 Million EUR | 8.22% |
| 2020 FY | 2.33 Billion EUR | 27.84% |
| 2020 Q4 | 655.65 Million EUR | 5.21% |
| 2020 Q3 | 623.2 Million EUR | 13.95% |
| 2020 Q2 | 546.9 Million EUR | 7.26% |
| 2019 Q4 | 471.16 Million EUR | 2.16% |
| 2019 Q2 | 459 Million EUR | 5.35% |
| 2019 Q1 | 435.7 Million EUR | 5.67% |
| 2019 Q3 | 461.2 Million EUR | 0.48% |
| 2019 FY | 1.82 Billion EUR | 16.66% |
| 2018 Q2 | 393.5 Million EUR | 7.84% |
| 2018 FY | 1.56 Billion EUR | 11.5% |
| 2018 Q4 | 412.33 Million EUR | 4.31% |
| 2018 Q3 | 395.3 Million EUR | 0.46% |
| 2018 Q1 | 364.9 Million EUR | 1.09% |
| 2017 Q1 | 343.1 Million EUR | 2.36% |
| 2017 FY | 1.4 Billion EUR | 8.02% |
| 2017 Q4 | 360.97 Million EUR | 6.32% |
| 2017 Q3 | 339.5 Million EUR | -5.96% |
| 2017 Q2 | 361 Million EUR | 5.22% |
| 2016 Q3 | 339.7 Million EUR | 5.01% |
| 2016 Q2 | 323.5 Million EUR | 7.15% |
| 2016 Q1 | 301.9 Million EUR | 6.13% |
| 2016 FY | 1.3 Billion EUR | 16.64% |
| 2016 Q4 | 335.19 Million EUR | -1.33% |
| 2015 Q2 | 277.3 Million EUR | 7.44% |
| 2015 Q1 | 258.1 Million EUR | 44.62% |
| 2015 FY | 1.11 Billion EUR | 25.09% |
| 2015 Q3 | 294.9 Million EUR | 6.35% |
| 2015 Q4 | 284.45 Million EUR | -3.54% |
| 2014 Q2 | 243.1 Million EUR | 8.96% |
| 2014 FY | 891.16 Million EUR | 0.44% |
| 2014 Q4 | 178.46 Million EUR | -27.6% |
| 2014 Q3 | 246.5 Million EUR | 1.4% |
| 2014 Q1 | 223.1 Million EUR | -2.99% |
| 2013 Q2 | 226.9 Million EUR | 5.88% |
| 2013 Q3 | 216 Million EUR | -4.8% |
| 2013 FY | 887.26 Million EUR | 4.91% |
| 2013 Q4 | 229.96 Million EUR | 6.47% |
| 2013 Q1 | 214.3 Million EUR | 3.87% |
| 2012 Q3 | 217.3 Million EUR | 1.54% |
| 2012 FY | 845.71 Million EUR | 15.36% |
| 2012 Q1 | 208.1 Million EUR | 8.56% |
| 2012 Q2 | 214 Million EUR | 2.84% |
| 2012 Q4 | 206.31 Million EUR | -5.06% |
| 2011 Q2 | 181.6 Million EUR | 5.52% |
| 2011 Q3 | 187.7 Million EUR | 3.36% |
| 2011 Q4 | 191.7 Million EUR | 2.13% |
| 2011 Q1 | 172.1 Million EUR | -2.78% |
| 2011 FY | 733.1 Million EUR | 11.19% |
| 2010 Q2 | 164.8 Million EUR | 9.57% |
| 2010 FY | 659.31 Million EUR | 9.51% |
| 2010 Q4 | 177.01 Million EUR | 5.93% |
| 2010 Q3 | 167.1 Million EUR | 1.4% |
| 2010 Q1 | 150.4 Million EUR | -4.44% |
| 2009 Q3 | 148.2 Million EUR | -1.53% |
| 2009 FY | 602.08 Million EUR | -1.56% |
| 2009 Q1 | 146 Million EUR | 0.0% |
| 2009 Q2 | 150.5 Million EUR | 3.08% |
| 2009 Q4 | 157.38 Million EUR | 6.2% |
| 2008 FY | 611.62 Million EUR | 3.84% |
| 2007 FY | 589.02 Million EUR | 13.05% |
| 2006 FY | 521.05 Million EUR | 7.59% |
| 2005 FY | 484.3 Million EUR | 3.58% |
| 2004 FY | 467.56 Million EUR | 5.72% |
| 2003 FY | 442.26 Million EUR | -7.19% |
| 2002 FY | 476.52 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Medical Technologies Inc. | 3.19 Million USD | -106299.112% |
| Ansell Limited | 1.61 Billion USD | -109.702% |
| Ansell Limited | 1.61 Billion USD | -109.702% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 184.64 Million USD | -1739.018% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -2514208.985% |
| Psykey, Inc. | 419.29 Thousand USD | -809751.681% |
| ConvaTec Group Plc | 2.19 Billion USD | -54.771% |
| ConvaTec Group Plc | 2.14 Billion USD | -58.5% |
| Encision Inc. | 6.58 Million USD | -51460.292% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 1.82 Million USD | -185973.4% |
| LifePoint, Inc. | -18.5 Thousand USD | 18355235.135% |
| Medite Cancer Diagnostics, Inc. | 6.81 Million USD | -49741.48% |
| Paradigm Medical Industries, Inc. | 772 Thousand USD | -439757.513% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 986.22 Thousand USD | -344214.656% |
| Reflect Scientific, Inc. | 1.08 Million USD | -314271.84% |
| SmileDirectClub, Inc. | 470.74 Million USD | -621.349% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | -81.432% |
| SheerVision, Inc. | 3.49 Million USD | -96936.441% |
| United Health Products, Inc. | - USD | -Infinity% |
| Vasamed, Inc. | 1.38 Million USD | -244848.041% |
| Wearable Health Solutions, Inc. | 745.09 Thousand USD | -455641.766% |
| Yubo International Biotech Limited | 104.28 Thousand USD | -3256135.436% |